- Home
- AOD vs CDNA Comparison
AOD vs CDNA Comparison
Compare AOD & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOD
- CDNA
- Stock Information
- Founded
- AOD 2006
- CDNA 1998
- Country
- AOD United Kingdom
- CDNA United States
- Employees
- AOD N/A
- CDNA N/A
- Industry
- AOD Investment Managers
- CDNA Medical Specialities
- Sector
- AOD Finance
- CDNA Health Care
- Exchange
- AOD Nasdaq
- CDNA Nasdaq
- Market Cap
- AOD 862.4M
- CDNA 712.2M
- IPO Year
- AOD N/A
- CDNA 2014
- Fundamental
- Price
- AOD $9.11
- CDNA $11.85
- Analyst Decision
- AOD
- CDNA Buy
- Analyst Count
- AOD 0
- CDNA 6
- Target Price
- AOD N/A
- CDNA $27.67
- AVG Volume (30 Days)
- AOD 423.5K
- CDNA 2.4M
- Earning Date
- AOD 01-01-0001
- CDNA 08-06-2025
- Dividend Yield
- AOD 12.95%
- CDNA N/A
- EPS Growth
- AOD 213.63
- CDNA N/A
- EPS
- AOD 1.93
- CDNA 1.00
- Revenue
- AOD $72,962,082.00
- CDNA $340,826,000.00
- Revenue This Year
- AOD N/A
- CDNA $12.81
- Revenue Next Year
- AOD N/A
- CDNA $13.36
- P/E Ratio
- AOD $4.44
- CDNA $12.00
- Revenue Growth
- AOD N/A
- CDNA 14.72
- 52 Week Low
- AOD $6.99
- CDNA $10.96
- 52 Week High
- AOD $9.14
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- AOD 61.87
- CDNA 32.40
- Support Level
- AOD $8.77
- CDNA $11.26
- Resistance Level
- AOD $9.15
- CDNA $13.28
- Average True Range (ATR)
- AOD 0.09
- CDNA 0.59
- MACD
- AOD -0.00
- CDNA 0.07
- Stochastic Oscillator
- AOD 88.16
- CDNA 38.35
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.